07/07/2014 - 6:50pm

Novo Nordisk on Monday announced that the Food and Drug Administration approved the company's NovoSeven RT (coagulation factor VIIa [recombinant]).

07/07/2014 - 1:23pm

According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot. 

07/03/2014 - 12:48pm

The Food and Drug Administration on Tuesday made available a draft of its strategic priorities over the next four years for public comment.

07/03/2014 - 11:53am

Novartis on Wednesday announced that it has begun shipment of its seasonal influenza vaccines to customers in the U.S. market for the 2014-2015 season.

07/03/2014 - 10:38am

A study published Tuesday online by the journal Pediatrics found that the protective benefits provided by vaccines for children significantly outweighed the extremely rare possiblity of an adverse event.

07/03/2014 - 10:33am

Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego. 

07/02/2014 - 2:17pm

Express Scripts has taken as many as 1,000 active ingredients widely used by compounding pharmacies off of their coverage list, according to a Wall Street Journal report published Tuesday. 

07/02/2014 - 12:33pm

Actavis on Wednesday announced that its subsidiary Forest Labs has successfully completed its acquisition of Furiex Pharmaceuticals in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug, following approval.

07/02/2014 - 12:17pm

Larry Hausner, CEO of the American Diabetes Association, on Tuesday announced that he will step down as CEO, effective July 31, 2014, to pursue new opportunities in his native New York metro area.